Current knowledge of intermittent photic stimulation for electroencephalography in dogs
Abstract
Intermittent photic stimulation is a standardized activation procedure for electroencephalography in humans that increases the detection of epileptic activity and improves diagnostic yield. However, its application in veterinary medicine remains inconsistent and methodologically heterogeneous. This narrative review synthesizes current knowledge regarding intermittent photic stimulation in dogs, critically evaluates variability in stimulus design, vigilance state, and electrode montage, and proposes a framework to support standardization in veterinary practice. Published veterinary studies demonstrate that photic stimulation can provoke generalized spike-wave and polyspike-wave discharges in selected epilepsy syndromes of dogs, particularly during awake recordings. However, protocols vary substantially in frequency range, light intensity, eye state control, flash duration, vigilance state, and lamp distance. Sedation and general anesthesia appear to attenuate retinal and thalamocortical responsiveness, decreasing the likelihood of eliciting photoparoxysmal responses. In addition, sparse and inconsistent electrode arrays limit spatial interpretation of photic responses and hinder cross-study comparisons. Drawing on established methodology used in humans and emerging veterinary data, this review outlines practical recommendations for standardized awake testing, defined stimulus parameters, and improved spatial sampling. Harmonized protocols may enhance diagnostic sensitivity,…
How strong is the evidence?
Evidence Hub reads this as a review, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.